Quest Diagnostics (DGX) Cash from Investing Activities (2016 - 2026)
Quest Diagnostics has reported Cash from Investing Activities over the past 18 years, most recently at -$152.0 million for Q1 2026.
- Quarterly results put Cash from Investing Activities at -$152.0 million for Q1 2026, down 32.17% from a year ago — trailing twelve months through Mar 2026 was -$668.0 million (up 72.73% YoY), and the annual figure for FY2025 was -$631.0 million, up 75.24%.
- Cash from Investing Activities reached -$152.0 million in Q1 2026 per DGX's latest filing, up from -$191.0 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$82.0 million in Q2 2022 and bottomed at -$1.6 billion in Q3 2024.
- Median Cash from Investing Activities over the past 5 years was -$169.0 million (2022), compared with a mean of -$290.3 million.
- The largest annual shift saw Cash from Investing Activities plummeted 1426.17% in 2024 before it surged 87.69% in 2025.
- Over 5 years, Cash from Investing Activities stood at -$174.0 million in 2022, then skyrocketed by 34.48% to -$114.0 million in 2023, then crashed by 340.35% to -$502.0 million in 2024, then surged by 61.95% to -$191.0 million in 2025, then grew by 20.42% to -$152.0 million in 2026.
- Business Quant data shows Cash from Investing Activities for DGX at -$152.0 million in Q1 2026, -$191.0 million in Q4 2025, and -$201.0 million in Q3 2025.